Found: 20
Select item for more details and to access through your institution.
Atorvastatin Decreased Circulating RANTES Levels in Impaired Glucose Tolerance Patients with Hypercholesterolemia: An Interventional Study.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 2, p. 309, doi. 10.1007/s13300-017-0227-x
- By:
- Publication type:
- Article
Evaluation of a Premixed Insulin Analog Suspension in Japanese People with Type 2 Diabetes and the Clinical Importance of Improved Injection Techniques: A Cross-Sectional Pilot Study.
- Published in:
- 2017
- By:
- Publication type:
- Report
Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors: Comparing Trial and Real World Use (Study Protocol).
- Published in:
- 2017
- By:
- Publication type:
- Report
Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 2, p. 275, doi. 10.1007/s13300-017-0236-9
- By:
- Publication type:
- Article
Effects of Canagliflozin on Serum Magnesium in Patients With Type 2 Diabetes Mellitus: A Post Hoc Analysis of Randomized Controlled Trials.
- Published in:
- 2017
- By:
- Publication type:
- Report
Fasting, Diabetes, and Optimizing Health Outcomes for Ramadan Observers: A Literature Review.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 2, p. 227, doi. 10.1007/s13300-017-0233-z
- By:
- Publication type:
- Article
Glycemic Control in a Real-Life Setting in Patients with Type 2 Diabetes Treated with IDegLira at a Single Swiss Center.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 2, p. 377, doi. 10.1007/s13300-017-0234-y
- By:
- Publication type:
- Article
Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 2, p. 213, doi. 10.1007/s13300-017-0235-x
- By:
- Publication type:
- Article
Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 2, p. 321, doi. 10.1007/s13300-017-0230-2
- By:
- Publication type:
- Article
A Large Difference in Dose Timing of Basal Insulin Introduces Risk of Hypoglycemia and Overweight: A Cross-Sectional Study.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 2, p. 385, doi. 10.1007/s13300-017-0238-7
- By:
- Publication type:
- Article
Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 2, p. 335, doi. 10.1007/s13300-017-0237-8
- By:
- Publication type:
- Article
Liraglutide Versus Lixisenatide: Long-Term Cost-Effectiveness of GLP-1 Receptor Agonist Therapy for the Treatment of Type 2 Diabetes in Spain.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 2, p. 401, doi. 10.1007/s13300-017-0239-6
- By:
- Publication type:
- Article
The Role of Dyslipidemia Control in the Progression of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 2, p. 209, doi. 10.1007/s13300-017-0240-0
- By:
- Publication type:
- Article
Effectiveness of Liraglutide and Lixisenatide in the Treatment of Type 2 Diabetes: Real-World Evidence from The Health Improvement Network (THIN) Database in the United Kingdom.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 2, p. 417, doi. 10.1007/s13300-017-0241-z
- By:
- Publication type:
- Article
Errors in the Administration Technique of Insulin Pen Devices: A Result of Insufficient Education.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 2, p. 221, doi. 10.1007/s13300-017-0242-y
- By:
- Publication type:
- Article
Comparative Effectiveness of Adding Alogliptin to Metformin Plus Sulfonylurea with Other DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 2, p. 251, doi. 10.1007/s13300-017-0245-8
- By:
- Publication type:
- Article
Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes.
- Published in:
- 2017
- By:
- Publication type:
- Erratum
Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitor: Comparing Trial Data and Real-World Use.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 2, p. 365, doi. 10.1007/s13300-017-0254-7
- By:
- Publication type:
- Article
PPAR-α Agonist Fenofibrate Reduces Insulin Resistance in Impaired Glucose Tolerance Patients with Hypertriglyceridemia: A Cross-Sectional Study.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 2, p. 433, doi. 10.1007/s13300-017-0257-4
- By:
- Publication type:
- Article
Effects of Acarbose on the Gut Microbiota of Prediabetic Patients: A Randomized, Double-blind, Controlled Crossover Trial.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 2, p. 293, doi. 10.1007/s13300-017-0226-y
- By:
- Publication type:
- Article